Egetis Therapeutics AB (OSTO:PLED BTA) FCF Margin % : -523.62% (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Egetis Therapeutics AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Egetis Therapeutics AB's Free Cash Flow for the three months ended in Mar. 2025 was kr-66.50 Mil. Egetis Therapeutics AB's Revenue for the three months ended in Mar. 2025 was kr12.70 Mil. Therefore, Egetis Therapeutics AB's FCF Margin % for the quarter that ended in Mar. 2025 was -523.62%.

As of today, Egetis Therapeutics AB's current FCF Yield % is -14.75%.

The historical rank and industry rank for Egetis Therapeutics AB's FCF Margin % or its related term are showing as below:

OSTO:PLED BTA' s FCF Margin % Range Over the Past 10 Years
Min: -771.11 Med: -411.77 Max: -75.87
Current: -510.68

During the past 13 years, the highest FCF Margin % of Egetis Therapeutics AB was -75.87%. The lowest was -771.11%. And the median was -411.77%.

OSTO:PLED BTA's FCF Margin % is ranked worse than
70.87% of 999 companies
in the Biotechnology industry
Industry Median: -100.31 vs OSTO:PLED BTA: -510.68

Egetis Therapeutics AB FCF Margin % Historical Data

The historical data trend for Egetis Therapeutics AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egetis Therapeutics AB FCF Margin % Chart

Egetis Therapeutics AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-331.18

-340.21

-771.11

-483.33

-494.36

Egetis Therapeutics AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
FCF Margin %	Get a 7-Day Free Trial															-457.85	-405.76	-664.89	-496.30	-523.62

Competitive Comparison of Egetis Therapeutics AB's FCF Margin %

For the Biotechnology subindustry, Egetis Therapeutics AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Egetis Therapeutics AB's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Egetis Therapeutics AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Egetis Therapeutics AB's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Egetis Therapeutics AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Egetis Therapeutics AB's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-227.9	/	46.1
	=	-494.36 %

Egetis Therapeutics AB's FCF Margin for the quarter that ended in Mar. 2025 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2025 )	/	Revenue (Q: Mar. 2025 )
	=	-66.5	/	12.7
	=	-523.62 %

Egetis Therapeutics AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Egetis Therapeutics AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Egetis Therapeutics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Egetis Therapeutics AB (OSTO:PLED BTA) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

EGTX:Sweden 0ABW:UK P0F:Germany

Address

Grev Turegatan 11 C, Stockholm, SWE, 114 46

Website

https://www.egetis.com

Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.

Egetis Therapeutics AB Headlines

No Headlines